WHO ICTRP trial
Effects of 1800 mg N-acetylcysteine in burnt patients with Acute Renal Failure
IRCT20100418003742N5 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20100418003742N5 |
|---|---|
| Public title | Effects of 1800 mg N-acetylcysteine in burnt patients with Acute Renal Failure |
| Scientific title | Effects of 1800 mg N-acetylcysteine in burnt patients with Acute Renal Failure |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acute Renal Failure in burninig patients. Acute kidney failure |
| Interventions | Intervention 1: Intervention group: Patients in case group will receive 1800 mg N-acetylcysteine in three divided doses. Intervention 2: Control group: Patients in the placebo group will be given in three divided doses. |
| Registration date | Jan 12, 2020 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: